Clinical Trials
All Clinical Trials - Page 71 of 75
A complete, crawlable index of every tracked clinical trial of peptide compounds. Use the search browser at /trials for filtering, or page through the full list here.
- NCT00130403Phase 4Completed
OPTAMISE: Clinical Effectiveness of Teriparatide After Alendronate or Risedronate Therapy in Osteoporotic Postmenopausal Women
Teriparatide
- NCT00076362Phase 4Completed
Pediatric Hypothalamic Obesity
Octreotide
- NCT00088582Phase 2Completed
Study Comparing SOM230 Subcutaneously and Sandostatin Subcutaneously in Acromegalic Patients
Octreotide
- NCT00099333Phase 2Completed
Study of the Safety of Substituting Exenatide for Insulin in Patients Using Insulin and Oral Antidiabetic Agents
Exenatide
- NCT00166725Phase 2Completed
Effects of Octreotide Acetate on Circulating Levels of Chromogranin A in Advanced Prostate Cancer Patients
Octreotide
- NCT00149188Phase 4Completed
Somatuline Autogel: Acromegaly Self/Partner Injection Study
Lanreotide
- NCT01060488Phase 3Completed
Comparative Validation of the Growth Hormone Releasing Hormone and Arginine Test for the Diagnosis of Adult Growth Hormone Deficiency
Sermorelin
- NCT00635258N/ACompleted
Administration of GnRH Antagonist to Oocyte Donation Recipients
Gonadorelin
- NCT01764230N/ACompleted
Prevention of Ovarian Function Damage by a GnRH Analogue During Chemotherapy in Hodgkin Lymphoma Patients
Gonadorelin
- NCT00088595Phase 2Completed
Study Evaluating SOM230 in Patients With Metastatic Carcinoid Tumors
Octreotide
- NCT00993356Phase 2Unknown
Preoperative Lanreotide Treatment in Acromegalic Patients With Macroadenomas
Lanreotide
- NCT01615978Phase 1Completed
Safety and Tolerability of Liraglutide in Japanese Subjects With Type 2 Diabetes
Liraglutide
- NCT01876849Phase 3Completed
An Open-Label Study Examining the Long-Term Safety of Exenatide Given Twice Daily to Patients With Type 2 Diabetes Mellitus
Exenatide
- NCT00065637Phase 3Completed
Once Weekly Parathyroid Hormone for Osteoporosis
Teriparatide
- NCT01611571Phase 3Completed
Combination Risedronate - Parathyroid Hormone Trial in Male Osteoporosis
Teriparatide
- NCT00466856Phase 2Terminated
Internal Radiation Therapy in Treating Patients With Liver Metastases From Neuroendocrine Tumors
Octreotide
- NCT00108355Phase 4Completed
Vasoconstrictors as Alternatives to Albumin After Large-Volume Paracentesis (LVP) in Cirrhosis
Octreotide
- NCT00075868Phase 3Completed
Octreotide in Preventing or Reducing Diarrhea in Patients Receiving Chemoradiotherapy for Anal or Rectal Cancer
Octreotide
- NCT00170742Phase 3Terminated
Study to Assess the Efficacy and Safety of Monthly Octreotide Intramuscular Injections in Patients With Proliferative Diabetic Retinopathy After Lasercoagulation This Study is Not Being Conducted in the United States.
Octreotide
- NCT00072839Phase 2Completed
Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease
Teduglutide
- NCT00082407Phase 3Completed
Exenatide Compared With Twice-Daily Biphasic Insulin Aspart in Patients With Type 2 Diabetes Using Sulfonylurea and Metformin
Exenatide
- NCT00532207Phase 3Completed
Study of Teriparatide in the Treatment of Postmenopausal Women With Osteoporosis
Teriparatide
- NCT00206297Phase 3Completed
The Effect of Prolonged Pramlintide Infusion in Pediatric Diabetes
Pramlintide
- NCT00068029Phase 4Completed
Pegvisomant And Sandostatin LAR Combination Study
Octreotide
- NCT00816127N/ACompleted
Prevention of Bleeding in Patient With Cirrhosis Undergoing Dental Extraction
Desmopressin
- NCT00417066Phase 4Completed
Flexible GnRH Antagonist vs Flare up GnRH Agonist Protocol in Poor Responders
Gonadorelin
- NCT01620476Phase 1Completed
Safety and Tolerability of Liraglutide in Healthy Japanese Volunteers
Liraglutide
- NCT00085969Phase 2Completed
Effect of Exenatide Monotherapy on Glucose Control in Subjects With Type 2 Diabetes Mellitus
Exenatide
- NCT00191893Phase 3Completed
Bone Effects of Teriparatide Following Alendronate
Teriparatide
- NCT00191802Phase 3Completed
Compliance and Acceptance of Teriparatide Injection in Severely Osteoporotic Patients
Teriparatide
- NCT00216372Phase 3Completed
Efficacy and Safety of Lanreotide Microparticles as Palliative Treatment in Peritoneal Carcinomatosis
Lanreotide
- NCT00066807Phase 3Terminated
Premenopausal Endocrine Responsive Chemotherapy Trial
Gonadorelin
- NCT01078805N/ACompleted
Study of FORTEO Use in Subjects in the Community Setting
Teriparatide
- NCT00542984Phase 3Completed
Comparison Medications in the Treatment of Postmenopausal Women With Osteoporosis
Teriparatide
- NCT00064714Phase 2Completed
Effect of AC2993 With or Without Immunosuppression on Beta Cell Function in Patients With Type I Diabetes
Exenatide
- NCT00835211Phase 1Completed
Desmopressin Acetate 0.2 mg Tablets, Fasting
Desmopressin
- NCT00592566Phase 2/Phase 3Terminated
Desmopressin and Dexamethasone Adjunctive Treatment for Leptospirosis
Desmopressin
- NCT00764166Phase 3Unknown
A Prospective Randomized Phase III Study Comparing Hormonal Therapy +/-Docetaxel
Gonadorelin
- NCT00082381Phase 3Completed
Effect of AC2993 Compared With Insulin Glargine in Patients With Type 2 Diabetes Also Using Combination Therapy With Sulfonylurea and Metformin
Exenatide
- NCT00543023Phase 3Completed
A Study of the Treatment of Postmenopausal Women With Osteoporosis
Teriparatide
- NCT00234520N/ACompleted
A Study to Evaluate the Risk of Developing a Heart Condition Called Valvular Regurgitation in Patients With Acromegaly Treated With Either Lanreotide or Octreotide
Octreotide
- NCT00220194Phase 4Completed
A Six-Month, Open-Label, Crossover Study Of the Maintenance Of Serum Testosterone And PSA Suppression After Switching Between Lupron 22.5 Mg And Eligard 22.5 Mg Or Zoladex 10.8 Mg And Eligard 22.5 Mg In Patients With Advanced Prostate Cancer
Gonadorelin
- NCT00582556Phase 2Completed
Zometa on Bone Mineral Density in Prostate Cancer Patients Undergoing Androgen Ablation Therapy
Gonadorelin
- NCT00108004Phase 3Completed
Clinical Utility and Safety of Pramlintide in Subjects With Type 1 and Type 2 Diabetes Mellitus
Pramlintide
- NCT00532545Phase 4Completed
Bone Marker Changes With Teriparatide/Postmenopausal Osteoporosis
Teriparatide
- NCT00068042Phase 4Completed
A Study To Compare The Efficacy And Safety Of Pegvisomant To That Of Sandostatin Lar Depot In Patients With Acromegaly
Octreotide
- NCT00621179Phase 4Completed
Endometrial Markers and Response of Endometriosis Patients to Prolonged GnRH Agonist Prior to IVF
Gonadorelin
- NCT00056654N/ACompleted
Study of a 6-Month Sustained-Release Formulation of Leuprolide Acetate in Prostate Cancer
Gonadorelin
- NCT00159328Phase 4Completed
Efficacy Study of Magnetic Resonance (MR) Guided Focused Ultrasound in the Treatment of Large Fibroids
Gonadorelin
- NCT00242541Phase 4Terminated
Study Assessing the Efficacy and Safety of Octreotide Acetate in Patients With Acromegaly, With Micro or Macroadenomas
Octreotide